Cardinal Capital Management Inc (Canada)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,135
| Closed | -$1.83M | – | 56 |
|
|
2023
Q2 | $1.83M | Sell |
18,135
-4,370
| -19% | -$437K | 0.09% | 44 |
|
|
2023
Q1 | $2.07M | Sell |
22,505
-600
| -3% | -$52.4K | 0.11% | 42 |
|
|
2022
Q4 | $2.1M | Sell |
23,105
-925
| -4% | -$77.9K | 0.12% | 42 |
|
|
2022
Q3 | $1.83M | Buy |
24,030
+660
| +3% | +$54.7K | 0.11% | 42 |
|
|
2022
Q2 | $1.98M | Sell |
23,370
-2,985
| -11% | -$262K | 0.11% | 43 |
|
|
2022
Q1 | $2.31M | Sell |
26,355
-154,571
| -85% | -$13.4M | 0.11% | 43 |
|
|
2021
Q4 | $15.8M | Buy |
180,926
+9,588
| +6% | +$796K | 0.74% | 36 |
|
|
2021
Q3 | $14M | Buy |
171,338
+6,593
| +4% | +$593K | 0.77% | 37 |
|
|
2021
Q2 | $15M | Buy |
164,745
+16,545
| +11% | +$1.47M | 0.81% | 34 |
|
|
2021
Q1 | $12.7M | Buy |
148,200
+16,730
| +13% | +$1.5M | 0.74% | 36 |
|
|
2020
Q4 | $12.4M | Buy |
131,470
+10,165
| +8% | +$888K | 0.75% | 34 |
|
|
2020
Q3 | $10.5M | Buy |
+121,305
| New | +$10.5M | 0.76% | 34 |
|
|
2019
Q2 | – | Sell |
-101,412
| Closed | -$8.74M | – | 50 |
|
|
2019
Q1 | $8.74M | Buy |
101,412
+2,159
| +2% | +$173K | 0.87% | 32 |
|
|
2018
Q4 | $7.63M | Sell |
99,253
-3,543
| -3% | -$276K | 0.89% | 30 |
|
|
2018
Q3 | $7.94M | Buy |
102,796
+1,334
| +1% | +$98.6K | 0.76% | 35 |
|
|
2018
Q2 | $6.87M | Buy |
101,462
+2,005
| +2% | +$138K | 0.66% | 36 |
|
|
2018
Q1 | $7.21M | Buy |
99,457
+5,357
| +6% | +$408K | 0.68% | 38 |
|
|
2017
Q4 | $7.08M | Buy |
94,100
+1,702
| +2% | +$128K | 0.6% | 37 |
|
|
2017
Q3 | $7.11M | Buy |
92,398
+2,751
| +3% | +$208K | 0.66% | 34 |
|
|
2017
Q2 | $6.71M | Buy |
89,647
+9,888
| +12% | +$701K | 0.68% | 33 |
|
|
2017
Q1 | $5.31M | Buy |
79,759
+6,918
| +9% | +$461K | 0.55% | 33 |
|
|
2016
Q4 | $4.75M | Buy |
72,841
+4,102
| +6% | +$266K | 0.51% | 32 |
|
|
2016
Q3 | $4.86M | Buy |
68,739
+1,455
| +2% | +$106K | 0.55% | 33 |
|
|
2016
Q2 | $4.97M | Buy |
67,284
+291
| +0.4% | +$20.1K | 0.55% | 35 |
|
|
2016
Q1 | $4.35M | Buy |
66,993
+3,844
| +6% | +$262K | 0.49% | 36 |
|
|
2015
Q4 | $4.87M | Buy |
63,149
+2,182
| +4% | +$173K | 0.61% | 34 |
|
|
2015
Q3 | $5.02M | Buy |
60,967
+3,850
| +7% | +$343K | 0.62% | 34 |
|
|
2015
Q2 | $5.03M | Buy |
57,117
+14,609
| +34% | +$1.34M | 0.55% | 34 |
|
|
2015
Q1 | $3.76M | Buy |
42,508
+8,386
| +25% | +$744K | 0.41% | 36 |
|
|
2014
Q4 | $2.83M | Buy |
34,122
+9,263
| +37% | +$768K | 0.31% | 36 |
|
|
2014
Q3 | $2.1M | Sell |
24,859
-7,131
| -22% | -$577K | 0.16% | 38 |
|
|
2014
Q2 | $2.77M | Buy |
31,990
+7,466
| +30% | +$587K | 1.18% | 22 |
|
|
2014
Q1 | $1.87M | Buy |
+24,524
| New | +$1.79M | 0.88% | 27 |
|
Other funds holding NVS
Cardinal Capital Management Inc (Canada)'s NVS Position: Q3 2023 in Review
Cardinal Capital Management Inc (Canada) sold out of Novartis (NVS) in Q3 2023, closing a stake of 18,135 shares — an estimated $1.83M sold.
Cardinal Capital Management Inc (Canada) first reported a position in NVS in Q1 2014 and held it in 33 quarters. The position peaked at $15.8M in Q4 2021. 1,224 funds tracked by Wall St. Rank hold NVS as of Q3 2023.
- Cardinal Capital Management Inc (Canada) reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
- Cardinal Capital Management Inc (Canada) sold 18,135 Novartis shares in Q3 2023, an estimated $1.83M.
- Cardinal Capital Management Inc (Canada) first reported a position in Novartis in Q1 2014 and held it in 33 quarters.
- Cardinal Capital Management Inc (Canada)'s Novartis position peaked at $15.8M in Q4 2021.
- 1,224 funds tracked by Wall St. Rank held Novartis as of Q3 2023.
Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q3 2023, filed 12 Oct 2023.